You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Formulation information for generic ingredient: emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate


✉ Email this page to a colleague

« Back to Dashboard


EMTRICITABINE

CASRN: 143491-57-0

Manufacturing Methods

<truncated in preview>

Rilpivirine

CASRN: 500287-72-9

Manufacturing Methods

<truncated in preview>

TENOFOVIR DISOPROXIL FUMARATE

CASRN: 202138-50-9

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing